AVITI24™ 2025 Innovation Roadmap
The next wave of innovation
Scientific discovery is never static, and neither is AVITI24. Built to change the way science happens, AVITI24 continues to expand with new capabilities that empower researchers to uncover deeper insights, ask more questions, and generate more meaningful data—all without sacrificing flexibility or performance.
AVITI24 drives discovery today and is ready to grow for tomorrow’s breakthroughs with expanded compatibility, new capabilities, and more customization options.
|
Product |
Description |
Availability |
|
Expanded Panel Content |
Expanded application use with new fixed Teton Immuno-Oncology and Neuroscience panels, including expanded sample type compatibility for cell suspensions and new segmentation algorithms for improved analysis. |
Now available |
|
Protein Customization |
Understand the targets that mean the most to your research with custom protein analysis. Includes:
|
H1 2025 |
|
48-well configuration |
High-throughput molecular profiling in a single run with 48-well configuration. |
H1 2025 |
|
Direct In Sample Sequencing |
Discovery and hypothesis driven read-outs in one experiment with Direct In Sample Sequencing.
|
Take a deep dive into our AVITI24 Innovation Roadmap and hear from early access users in our on-demand webinar.
Decode the complexities of neuroscience and accelerate breakthroughs in immuno-oncology research
With our new Teton neuroscience and immune-oncology panels, you’ll get:
- Automated, onboard detection of 350 RNA transcripts, 50 proteins (including phospho-proteins), and 6 cell morphology markers with a biologically relevant and supported panel.
- Simultaneous analysis of cell typing markers, signaling molecules, and important drivers of cell function.
- Advanced segmentation models for high-quality data for both intracellular and surface markers.
Teton Neuroscience Panel
The comprehensive neuroscience panel includes biologically relevant targets for research into neurodegenerative disorders, like Alzheimer’s and Parkinson’s disease, addiction, psychiatric disorders, and neurological cancers.
Teton neuroscience panel reveals accumulated phosphorylated Tau (S396) in dendrites. View all targets in the panel.
 Undifferentiated SH-SY5Y |
 Differentiated SH-SY5Y |
Neuroinflammation
Explore immune responses in the brain and how they may contribute to disease.
Neurotransmission and synaptic function
Identify drivers of neural cell function, neurotransmitter signaling, and synapse formation.
Neurodevelopment and differentiation
Discover gene-regulatory dynamics that control the formation and specialization of neurons.
Neurodegeneration
Understand disease progression, neuronal loss, and protein aggregation with markers for Alzheimer’s and Parkinson’s disease.
See how Matt Tegtmeyer, Purdue University used the neuroscience panel for high-dimensional phenotyping.
Teton Immuno-Oncology Panel
Advance your immuno-oncology research with the co-detection of immune cell markers, cytokines, signaling molecules, and biologically relevant targets involved in inflammation, innate and adaptive immunity, antiviral defense, and immune checkpoints.
Expanded sample compatibility with cell suspensions, such as Raji B cell lines (left) and PBMCs (right). View all targets in the immuno panel.
 Raji |
 PBMCs |
Immunophenotyping
Map immune repertoires and identify rare subpopulations of cells.
Immune Response and Signaling
Shed light on the inflammatory response and signaling pathways driving normal and abnormal cell function.
Immune Monitoring
Research the response of immuno-oncology drug targets like checkpoint inhibitors and cell therapies.
Hematology Oncology
Understand clonal hematopoiesis and mechanisms of leukemia, lymphoma, and myeloma.